{"id": "1356741522557972482", "creation": 1612307360.0, "user_id": "15511055", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "THREAD by @TheLancet: NEW:\n\u2022\nInterim analysis of Russian #COVID19 #vaccine phase 3 trial involving nearly 20,000 participants suggests a two-dose regimen has an efficacy of 91.6% against symptomatic #COVID19. \n1/\nhttps://t.co/MBaRSC3S8c", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#COVID19"]}